Skip to main content
. 2010 May 21;95(6):976–982. doi: 10.3324/haematol.2009.018267

Figure 2.

Figure 2.

(A) Effect of age in patients receiving FCA (left panel), stratified by the median age of 13 years. A significant disadvantage can be seen for patients greater than 13 years of age. (B) The right panel shows no age effect in patients receiving FCA-TBI, stratified by the median age of 27 years.